Decision of the Bioethics Commission at the Federal Chancellery of 3 April and 8 May 2002. Opinion of the Bioethics Commission on the issue of stem cell research in the context of the EU?s Sixth Framework Programme for Research, Technological Development and Demonstration Activities as a contribution towards the realization of the European Research Area (2002-2006)
Austria. Bioethikkommission beim Bundeskanzleramt = Austria. Bioethics Commission at the Federal Chancellery
Vienna, Austria: Bioethikkommission beim Bundeskanzleramt; 2002 April 3 [and] 2002 May 8; 6 p.
According to the EU s FAQ on the Research Framework Programme (FP), the FP is the EU s main instrument for research funding in Europe. The FP is proposed by the European Commission and adopted by the Council and the European parliament following a co-decision procedure. FPS cover a period of five years with the last year of one FP and the first year of the following FP overlapping. FPS have been implemented since 1984. The Sixth FP (FP6) will be fully operational as of January 1, 2003. . . . FP6 aims to contribute to the creation of a true European Research Area (ERA). ERA is a vision for the future of research in Europe, an internal market for science and technology.
Showing items related by title, author, creator and subject.
Decision of the Bioethics Commission at the Federal Chancellery of 6 March 2002. Opinion of the Bioethics Commission on the issue of national implementation of the Council Directive 98/44/EC on the legal protection of biotechnological inventions Austria. Bioethikkommission beim Bundeskanzleramt = Austria. Bioethics Commission at the Federal Chancellery (2002-03-06)